Methods for manufacture of valve flaps for cardiac valve prostheses

• US 4,624,822 A
• Filed: 07/25/1984
• Issued: 11/25/1986
• Est. Priority Date: 07/25/1983
• Status: Expired due to Term

• Current Assignee: Sorin Biomedica Cardio Srl (LivaNova Plc)
• Original Assignee: Sorin Biomedica SpA (Snia SpA)
• Inventors: Vallana, Franco, Curcio, Maria, Arru, Pietro, Bona, Gioacchino
• Primary Examiner(s): SILBAUGH, JAN H
• Application Number:
  US06/634,085
• Time in Patent Office: 853 Days
• Field of Search: 264/544, 264/570, 264/500, 3/1.5, 8/94.11, 69/21, 69/29, 623/2
• US Class Current: 264/544
• CPC Class Codes: A61F 2/24 Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
• CPC Class Codes: A61F 2/2415 Manufacturing methods
• CPC Class Codes: A61F 2220/0075 sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
• CPC Class Codes: A61F 2310/00161 Carbon; Graphite
• CPC Class Codes: A61K 35/30 Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
• CPC Class Codes: A61K 35/34 Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes vascular smooth muscle A61K35/44
• CPC Class Codes: A61L 27/08 Carbon ; Graphite
• CPC Class Codes: A61L 27/36 containing ingredients of undetermined constitution or reaction products thereof , e.g. transplant tissue, natural bone, extracellular matrix isolated natural compounds, e.g. collagen A61L27/24
• CPC Class Codes: A61L 27/3683 subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
• CPC Class Codes: A61L 27/507 for artificial blood vessels apparatus for applying cells on a blood vessel prosthesis A61F2/062
• CPC Class Codes: Y10S 623/901 Method of manufacturing prosthetic device

Abstract

Sheets of incompletely fixed biological tissue comprising portions for defining valve flaps of a cardiac valve prosthesis are mounted on forming means which can separate in a substantially fluid-tight manner the opposite faces of such portions. These opposite faces are subjected to a fluid pressure difference which produces deformation of the portions towards a conformation substantially identical with the conformation of the valve flaps when mounted in the prosthesis. The biological tissue is finally fixed while the portions defining the valve flaps of the prosthesis are maintained in the said conformation. The sheets of biological tissue are then separated from the forming means to be subsequently mounted in the frame of the prosthesis.

Claims

1. A process for the manufacture of valve flaps for a cardiac prosthesis from a sheet of biological tissue free of such flaps, comprising:

providing forming means having spaced apertures therein,

applying the sheet of biological tissue free of valve flaps to said forming means with portions of the biological tissue extending over the spaced apertures in a fluid-tight manner,

generating a fluid pressure differential across opposite surfaces of said portions of the biological tissue extending over said apertures to deform said portions into conformations substantially the same as the conformations of the valve flaps when mounted in a prothesis,

effecting formal fixation of the biological tissue while maintaining a pressure differential across said opposite surfaces of said formed valve flap portions to substantially stablize said valve flap portions, and

removing the biological tissue with its substantially stable valve flap portions from said forming means.

2. The process defined in claim 1, wherein the final fixation of the biological tissue is effected by means of a fixation fluid brought into contact with at least one of the opposite faces of the said portions of biological tissue.

3. The process defined in claim 2, wherein said pressure difference is generated by pressurising the fixation fluid and bringing the pressurised fixation fluid into contact with one of the opposite faces of the said portions of biological tissue.

4. The process defined in claim 3, wherein said portions of biological tissue are substantially immersed in the fixation fluid and wherein the said pressure difference is established between the bodies of fixation fluid which are in contact with the opposite faces of the said portions.

5. The process defined in claim 4, wherein the magnitude of said pressure difference and the length of time for fixation of the biological tissue are selected so as to effect a substantial diffusion of the fixation liquid through the said deformed portion of biological tissue.

6. A process for the manufacture of valve flaps for cardiac prostheses of the kind comprising a frame capable of being traversed by a flow of blood and a sleeve of biological tissue, with a plurality of valve flaps anchored to the frame along respective crescent shaped edges and provided with free edges projecting inwardly of the frame, capable of being separated by blood flowing through the prosthesis in one direction and of preventing the flow of blood in the opposite direction by moving to closely matching positions under the pressure exerted by the blood itself, wherein the process comprises:

providing a forming element of substantially tubular form for the sleeve, the wall of which has angularly adjacent apertures corresponding in number to the number of valve flaps of the sleeve and separated from one another by shaped wall elements extending in an axial direction with respect to the forming element;

said apertures having corresponding end edges the shape of which reproduces the shape of the said crescent shaped edges of the valve flaps of the sleeve,

sealingly fitting a tubular sheath of incompletely fixed biological tissue over said forming element,

establishing a pressure difference between the interior and the exterior of the forming element such that the portions of the sheath of biological tissue facing the said apertures of the forming element are pressed inwardly of said cavity in an arrangement in which the sheath portions deformed by the effect of such pressure difference converge radially into the forming element in partial matching conditions, each having at least one crescent shaped edge,

effecting the final fixation of the biological tissue of the sheath while maintaining said pressure difference between the interior cavity of the forming element and the exterior of the element itself, such that each of the said portions assumes, in a substantially stable manner, the deformed conformation achieved by the effect of the said pressure difference, by virtue of said final fixation, and

separating the finally fixed biological tissue of the sheath along a line joining the ends of the crescent shaped edges of the said stably deformed portions of sheath to create in each of such portions a free edge defining the free edge of the valve flap of the sleeve.

7. The process defined in claim 6, wherein the said sheath is obtained starting from a sheet of biological tissue formed into a tube by bringing two opposite edges of such sheet together and connecting them by suturing said edges.

8. The process defined in claim 6 wherein the tubular sheath is fixed to the forming element by means of resilient sealing rings fitted over the forming element on opposite sides of said apertures.